Results 301 to 310 of about 556,334 (392)

Heavyweight Champion: Caesium Diorganophosphides Outperform Lighter Congeners in the Catalytic Hydrophosphination of Alkenes and Alkynes

Angewandte Chemie, EarlyView.
The heavier, the better! We report that the caesium congener is the most active and versatile catalyst amongst a full group set of well‐defined crown ether supported alkali metal diphenyl phosphides for catalytic hydrophosphination of various substrates and phosphines including aryl and alkyl phosphines.
Felix Krämer, Michelle H. Crabbe, Israel Fernández, Robert E. Mulvey   +3 more
wiley   +2 more sources

In Vitro Silencing of MHC-I in Keratinocytes by Herpesvirus US11 Protein to Model Alloreactive Suppression. [PDF]

Eur Burn J
Schlottmann F, Strauß S, Vogt PM, Bucan V.   +3 more
europepmc   +1 more source

Emerging Strategies for Platelet‐Modified Nanoparticles in Targeted Tumor Therapy

Advanced NanoBiomed Research, EarlyView.
This review highlights innovative strategies using platelet‐modified nanoparticles to target tumors more precisely. By mimicking platelet functions, these biomimetic carriers improve tumor homing, enhance drug delivery, and reduce immune clearance.
Chunyu Bai, Lan Sun, Yimin Cui, Huan Meng, Jiulong Li, Qian Xiang   +5 more
wiley   +1 more source

Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy. [PDF]

Explor Target Antitumor Ther
Anilkumar AS, Thomas SM, Veerabathiran R.   +2 more
europepmc   +1 more source

Metabolism‐Regulating Nanomedicines for Cancer Therapy

Advanced NanoBiomed Research, EarlyView.
This review highlights metabolism‐regulating nanomedicines designed to target glycolytic, lipid, amino acid, and nucleotide pathways in tumors. By incorporating metabolism‐regulating agents into versatile nanocarriers such as liposomes, micelles, dendrimers, and engineered bacteria, these platforms achieve targeted delivery, controlled release ...
Xiao Wu, Shiyi Geng, Jian Yang
wiley   +1 more source

Immune Surveillance and Immune Escape in Cancer: Mechanisms and Immunotherapy. [PDF]

MedComm (2020)
Peng Y, Zhan L, Shi J, Wang J, Li Y, Sun X, Lv J, Yang H, Qiu Z, Liu X, Li C, Gong S, Jia W, Wang H, Zhao Y, Zhang B, Guo W, Guo J, Shang J, Zhou Q, Yang Y, Gao F.   +21 more
europepmc   +1 more source

Silica Nanoparticles as Multifunctional Platforms for Vaccine Delivery and Immune Modulation in Infectious Diseases

Advanced NanoBiomed Research, EarlyView.
Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez, Julio García‐Cordero, Gabriela Navarro‐Tovar, Leticia Cedillo‐Barrón   +3 more
wiley   +1 more source

Pan-Specific Prediction of Peptide–MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity

Journal of Immunology, 2016
M. Rasmussen, E. Fenoy, M. Harndahl, Anne B. Kristensen, Ida Kallehauge Nielsen, M. Nielsen, S. Buus   +6 more
semanticscholar   +1 more source

Unmasking Budgerigar Splenic Leukocyte Populations With Single-Cell Transcriptomics and Multiplex RNA In Situ Hybridization. [PDF]

J Immunol Res
De Meyst A, Lemeire K, Gonçalves A, Vandamme N, Vanrompay D.   +4 more
europepmc   +1 more source

Structure of the TAPBPR–MHC I complex defines the mechanism of peptide loading and editing

Science, 2017
Christoph Thomas, R. Tampé
semanticscholar   +1 more source